PL1922320T3 - Pochodne 5-pirydazynylo-1-azabicyklo[3.2.1]oktanu, ich wytwarzanie i ich zastosowanie terapeutyczne - Google Patents

Pochodne 5-pirydazynylo-1-azabicyklo[3.2.1]oktanu, ich wytwarzanie i ich zastosowanie terapeutyczne

Info

Publication number
PL1922320T3
PL1922320T3 PL06794297T PL06794297T PL1922320T3 PL 1922320 T3 PL1922320 T3 PL 1922320T3 PL 06794297 T PL06794297 T PL 06794297T PL 06794297 T PL06794297 T PL 06794297T PL 1922320 T3 PL1922320 T3 PL 1922320T3
Authority
PL
Poland
Prior art keywords
azabicyclo
pyridazinyl
therapeutics
octane
derivatives
Prior art date
Application number
PL06794297T
Other languages
English (en)
Inventor
Frédéric Galli
Odile Leclerc
Alistair W Lochead
Julien Vache
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36297201&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1922320(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PL1922320T3 publication Critical patent/PL1922320T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL06794297T 2005-08-18 2006-08-07 Pochodne 5-pirydazynylo-1-azabicyklo[3.2.1]oktanu, ich wytwarzanie i ich zastosowanie terapeutyczne PL1922320T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0508594A FR2889847B1 (fr) 2005-08-18 2005-08-18 Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
PCT/FR2006/001911 WO2007020343A1 (fr) 2005-08-18 2006-08-07 Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
EP06794297A EP1922320B1 (fr) 2005-08-18 2006-08-07 Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
PL1922320T3 true PL1922320T3 (pl) 2011-04-29

Family

ID=36297201

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06794297T PL1922320T3 (pl) 2005-08-18 2006-08-07 Pochodne 5-pirydazynylo-1-azabicyklo[3.2.1]oktanu, ich wytwarzanie i ich zastosowanie terapeutyczne

Country Status (39)

Country Link
US (3) US7476674B2 (pl)
EP (1) EP1922320B1 (pl)
JP (1) JP5249758B2 (pl)
KR (1) KR101260546B1 (pl)
CN (2) CN101291933B (pl)
AR (1) AR056461A1 (pl)
AT (1) ATE486073T1 (pl)
AU (1) AU2006281340B2 (pl)
BR (1) BRPI0614796A2 (pl)
CA (1) CA2618110C (pl)
CR (1) CR9693A (pl)
CY (1) CY1111101T1 (pl)
DE (1) DE602006017854D1 (pl)
DK (1) DK1922320T3 (pl)
DO (1) DOP2006000191A (pl)
EA (1) EA013601B1 (pl)
EC (1) ECSP088182A (pl)
ES (1) ES2354833T3 (pl)
FR (1) FR2889847B1 (pl)
HN (1) HN2008000276A (pl)
HR (1) HRP20110043T1 (pl)
IL (1) IL189014A0 (pl)
JO (1) JO2680B1 (pl)
MA (1) MA29913B1 (pl)
MX (1) MX2008002276A (pl)
MY (1) MY145923A (pl)
NO (1) NO20081289L (pl)
NZ (1) NZ565537A (pl)
PE (1) PE20070234A1 (pl)
PL (1) PL1922320T3 (pl)
PT (1) PT1922320E (pl)
RS (1) RS51653B (pl)
SI (1) SI1922320T1 (pl)
TN (1) TNSN08026A1 (pl)
TW (1) TWI322808B (pl)
UA (1) UA92360C2 (pl)
UY (1) UY29756A1 (pl)
WO (1) WO2007020343A1 (pl)
ZA (1) ZA200800966B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9249307B2 (en) 2011-08-16 2016-02-02 Pierce Biotechnology, Inc. Benzocyanine compounds
CA3105681A1 (en) 2018-07-19 2020-01-23 Sumitomo Dainippon Pharma Co., Ltd. Pyridazinone derivative
US20230109839A1 (en) 2020-01-07 2023-04-13 Sumitomo Pharma Co., Ltd. Therapeutic agent for tauopathies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
US6277855B1 (en) 2000-04-21 2001-08-21 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
ES2223209B1 (es) 2001-12-11 2005-10-01 Esteve Quimica, S.A. Nuevas formas cristalinas del meloxicam y procedimientos para su preparacion e interconversion.
DE60122015T2 (de) 2000-10-13 2006-11-23 Neurosearch A/S Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
US6644511B2 (en) 2002-01-11 2003-11-11 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Container for dispensing a dual phase fluid product

Also Published As

Publication number Publication date
NZ565537A (en) 2011-04-29
US20090088440A1 (en) 2009-04-02
US20080176855A1 (en) 2008-07-24
HRP20110043T1 (hr) 2011-02-28
JO2680B1 (en) 2013-03-03
MY145923A (en) 2012-05-15
HN2008000276A (es) 2011-03-30
CN101291933A (zh) 2008-10-22
PE20070234A1 (es) 2007-03-26
CN102558177A (zh) 2012-07-11
DE602006017854D1 (de) 2010-12-09
JP2009504714A (ja) 2009-02-05
UY29756A1 (es) 2007-03-30
AU2006281340A1 (en) 2007-02-22
UA92360C2 (en) 2010-10-25
MA29913B1 (fr) 2008-11-03
KR20080034468A (ko) 2008-04-21
RS51653B (sr) 2011-10-31
TW200738715A (en) 2007-10-16
DK1922320T3 (da) 2011-02-21
WO2007020343A1 (fr) 2007-02-22
CA2618110A1 (fr) 2007-02-22
KR101260546B1 (ko) 2013-05-06
EP1922320B1 (fr) 2010-10-27
EA200800615A1 (ru) 2008-06-30
DOP2006000191A (es) 2011-11-15
CY1111101T1 (el) 2015-06-11
MX2008002276A (es) 2008-03-27
HK1125628A1 (en) 2009-08-14
IL189014A0 (en) 2008-08-07
TNSN08026A1 (en) 2009-07-14
AR056461A1 (es) 2007-10-10
ZA200800966B (en) 2009-04-29
SI1922320T1 (sl) 2011-02-28
JP5249758B2 (ja) 2013-07-31
US8076340B2 (en) 2011-12-13
US8557819B2 (en) 2013-10-15
EP1922320A1 (fr) 2008-05-21
ATE486073T1 (de) 2010-11-15
US7476674B2 (en) 2009-01-13
ES2354833T3 (es) 2011-03-18
BRPI0614796A2 (pt) 2011-04-12
PT1922320E (pt) 2011-01-19
US20120046298A1 (en) 2012-02-23
CN101291933B (zh) 2012-03-14
EA013601B1 (ru) 2010-06-30
ECSP088182A (es) 2008-03-26
NO20081289L (no) 2008-03-17
TWI322808B (en) 2010-04-01
CA2618110C (fr) 2014-02-11
AU2006281340B2 (en) 2012-04-12
FR2889847A1 (fr) 2007-02-23
CR9693A (es) 2008-03-06
FR2889847B1 (fr) 2007-10-05

Similar Documents

Publication Publication Date Title
IL185034A0 (en) 1,5-diarylpyrrole derivatives, preparation method thereof and application of same in therapeutics
IL185163A0 (en) (1,5 - diphenyl - 1h - pyrazol - 3 - yl) oxadiazole derivatives, preparation method thereof and use of same in therapeutics
EP1784163A4 (en) NANOEMULSION, USE THEREOF AND PROCESS FOR PREPARING THE SAME
IL186118A0 (en) 1h-pyrazole 4-carboxylamides, their preparation and their use as 11beta- hydroxysteroid dehydrogenase
PT2044036E (pt) Derivados de [4,5′]bipirimidinil-6,4′-diamina como inibidores de proteína quinase
WO2004096798A3 (fr) Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique
IL192009A0 (en) Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
TWI350286B (en) Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy
IL179424A0 (en) Substituted oxazole -benzoisothiazole dioxide derivatives, process for their preparation and their use
AP2590A (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
IL176769A0 (en) Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
ZA200900835B (en) 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
ZA200801896B (en) Slow-release composition, method for the preparation thereof, and use of the same
ZA200902630B (en) Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-A]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-A]pyrimidin-6-one derivatives
IL202677A0 (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
IL188032A0 (en) Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics
ZA200609820B (en) Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
ZA200800966B (en) Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
PL370065A1 (pl) Pochodne 5-(pirydyn-3-ylo)-1-azabicyklo[3.2.1]oktanu, ich wytwarzanie i ich zastosowanie terapeutyczne
FR2874012B1 (fr) Derives de pyrrole, leur preparation et leur utlisation en therapeutique
IL176701A0 (en) Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
IL188185A0 (en) Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents
TWI349004B (en) 2h- or 3h-benzo[e]indazol-1-yl carbamate derivatives, their preparation and their application in therapeutics
ZA200704806B (en) Novel betulin derivatives, preparation thereof and use thereof
SI1708994T1 (sl) Derivati tipa ariloksialkilkarbamatov, njihova priprava in njihova terapevtska uporaba